Login / Signup
Martin Holst
(M R Holst)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 7
Top Topics
Double Blind
Clinical Trial
Primary Care
Hiv Infected
Top Venues
Trials
BMC research notes
Health research policy and systems
PLoS medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Martin Holst
,
Benjamin Gregory Carlisle
Trials that turn from retrospectively registered to prospectively registered: a cohort study of "retroactively prospective" clinical trial registration using history data.
Trials
25 (1) (2024)
Martin Holst
,
Benjamin Gregory Carlisle
Trials that turn from retrospectively registered to prospectively registered: a cohort study of "retroactively prospective" clinical trial registration using history data.
Trials
25 (1) (2024)
Martin Holst
,
Benjamin Gregory Carlisle
Trials that turn from retrospectively registered to prospectively registered: a cohort study of "retroactively prospective" clinical trial registration using history data.
Trials
25 (1) (2024)
Martin Holst
,
Benjamin Gregory Carlisle
Trials that turn from retrospectively registered to prospectively registered: a cohort study of "retroactively prospective" clinical trial registration using history data.
Trials
25 (1) (2024)
Martin Holst
,
Martin Haslberger
,
Samruddhi Yerunkar
,
Daniel Strech
,
Lars G Hemkens
,
Benjamin Gregory Carlisle
Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study.
PLoS medicine
20 (10) (2023)
Natascha Ingrid Drude
,
Lorena Martinez-Gamboa
,
Tamarinde Laura Haven
,
Constance Holman
,
Martin Holst
,
Silke Kniffert
,
Sarah K McCann
,
Torsten Rackoll
,
Robert Schulz
,
Sarah Weschke
Finding the best fit for improving reproducibility: reflections from the QUEST Center for Responsible Research.
BMC research notes
15 (1) (2022)
Martin Holst
,
Alice Faust
,
Daniel Strech
Do German university medical centres promote robust and transparent research? A cross-sectional study of institutional policies.
Health research policy and systems
20 (1) (2022)